WO1999030718A3 - COMBINAISON DE PROSTAGLANDINES E2/F2α, DESTINEE AU TRAITEMENT DE L'IMPUISSANCE ET A L'ACCROISSEMENT DE L'EXCITATION SEXUELLE - Google Patents
COMBINAISON DE PROSTAGLANDINES E2/F2α, DESTINEE AU TRAITEMENT DE L'IMPUISSANCE ET A L'ACCROISSEMENT DE L'EXCITATION SEXUELLE Download PDFInfo
- Publication number
- WO1999030718A3 WO1999030718A3 PCT/US1998/026609 US9826609W WO9930718A3 WO 1999030718 A3 WO1999030718 A3 WO 1999030718A3 US 9826609 W US9826609 W US 9826609W WO 9930718 A3 WO9930718 A3 WO 9930718A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prostaglandin
- sexual arousal
- combination
- treating
- treating impotence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98963194A EP1059926A2 (fr) | 1997-12-18 | 1998-12-15 | COMBINAISON DE PROSTAGLANDINES E 2?/F 2$g(a)?, DESTINEE AU TRAITEMENT DE L'IMPUISSANCE ET A L'ACCROISSEMENT DE L'EXCITATION SEXUELLE |
CA002314369A CA2314369A1 (fr) | 1997-12-18 | 1998-12-15 | Combinaison de prostaglandines e2/f2.alpha., destinee au traitement de l'impuissance et a l'accroissement de l'excitation sexuelle |
AU18272/99A AU1827299A (en) | 1997-12-18 | 1998-12-15 | Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal |
US09/422,031 US6291528B1 (en) | 1991-07-03 | 1999-10-20 | Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/992,946 | 1997-12-18 | ||
US08/992,946 US5981593A (en) | 1991-07-03 | 1997-12-18 | Prostaglandin E2 treatment of impotence |
US508798A | 1998-01-09 | 1998-01-09 | |
US09/005,087 | 1998-01-09 | ||
US09/038,378 US5962528A (en) | 1991-07-03 | 1998-03-11 | Prostaglandin E2 /F2α combination for treating impotence |
US09/038,378 | 1998-03-11 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/038,378 Continuation-In-Part US5962528A (en) | 1991-07-03 | 1998-03-11 | Prostaglandin E2 /F2α combination for treating impotence |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/422,031 Continuation-In-Part US6291528B1 (en) | 1991-07-03 | 1999-10-20 | Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999030718A2 WO1999030718A2 (fr) | 1999-06-24 |
WO1999030718A3 true WO1999030718A3 (fr) | 1999-09-10 |
Family
ID=27357802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/026609 WO1999030718A2 (fr) | 1991-07-03 | 1998-12-15 | COMBINAISON DE PROSTAGLANDINES E2/F2α, DESTINEE AU TRAITEMENT DE L'IMPUISSANCE ET A L'ACCROISSEMENT DE L'EXCITATION SEXUELLE |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1059926A2 (fr) |
CN (1) | CN1282249A (fr) |
AU (1) | AU1827299A (fr) |
CA (1) | CA2314369A1 (fr) |
WO (1) | WO1999030718A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE43372E1 (en) | 1999-03-05 | 2012-05-08 | Duke University | C16 unsaturated FP-selective prostaglandins analogs |
US8906962B2 (en) | 2000-03-31 | 2014-12-09 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US9346837B2 (en) | 2000-03-31 | 2016-05-24 | Duke University | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6251436B1 (en) * | 1995-09-29 | 2001-06-26 | L.A.M. Pharmaceutical Corporation | Drug preparations for treating sexual dysfunction |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
AU3713600A (en) | 1999-03-01 | 2000-09-21 | Nitromed, Inc. | Nitrosated and nitrosylated prostaglandins, compositions and metods of use |
WO2000053148A2 (fr) * | 1999-03-08 | 2000-09-14 | Merck & Co., Inc. | Procedes et compositions pour le traitement de la dyserection |
IL139457A0 (en) * | 1999-11-08 | 2001-11-25 | Pfizer | Compounds for the treatment of female sexual dysfunction |
DK1280531T3 (da) * | 2000-05-12 | 2007-05-29 | Novalar Pharmaceuticals Inc | Formulering bestående af phentolaminmesylat og anvendelse heraf |
SE0100158D0 (sv) * | 2001-01-19 | 2001-01-19 | Synphora Ab | Novel method and composition for local treatment of Meniere´s disease and tinnitus |
AU2009301392B9 (en) * | 2008-10-10 | 2018-05-24 | Implantica Patent Ltd. | Stimulation of sexually responsive tissue of the vulva |
US9757330B2 (en) | 2013-10-18 | 2017-09-12 | Industrial Technology Research Institute | Recipe for in-situ gel, and implant, drug delivery system formed thereby |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3917864A (en) * | 1973-02-12 | 1975-11-04 | Sultanali M M Karim | Use of prostaglandins E and F for induction of labor |
US4005221A (en) * | 1974-04-01 | 1977-01-25 | Karim Sultanali M M | Use of prostaglandins to induce menstruation |
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
EP0357581A1 (fr) * | 1988-09-02 | 1990-03-07 | AMSU, Ltd. | Composition pour le traitement de troubles de l'érection |
WO1991016021A1 (fr) * | 1990-04-25 | 1991-10-31 | Alza Corporation | Traitement de dysfonctionnement erectile |
WO1993000894A1 (fr) * | 1991-07-03 | 1993-01-21 | Scott Nathan E | Traitement de l'impuissance a l'aide de prostaglandine e2 |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
-
1998
- 1998-12-15 CA CA002314369A patent/CA2314369A1/fr not_active Abandoned
- 1998-12-15 CN CN 98812205 patent/CN1282249A/zh active Pending
- 1998-12-15 WO PCT/US1998/026609 patent/WO1999030718A2/fr not_active Application Discontinuation
- 1998-12-15 AU AU18272/99A patent/AU1827299A/en not_active Abandoned
- 1998-12-15 EP EP98963194A patent/EP1059926A2/fr not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3917864A (en) * | 1973-02-12 | 1975-11-04 | Sultanali M M Karim | Use of prostaglandins E and F for induction of labor |
US4005221A (en) * | 1974-04-01 | 1977-01-25 | Karim Sultanali M M | Use of prostaglandins to induce menstruation |
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
EP0357581A1 (fr) * | 1988-09-02 | 1990-03-07 | AMSU, Ltd. | Composition pour le traitement de troubles de l'érection |
WO1991016021A1 (fr) * | 1990-04-25 | 1991-10-31 | Alza Corporation | Traitement de dysfonctionnement erectile |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
WO1993000894A1 (fr) * | 1991-07-03 | 1993-01-21 | Scott Nathan E | Traitement de l'impuissance a l'aide de prostaglandine e2 |
US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE43372E1 (en) | 1999-03-05 | 2012-05-08 | Duke University | C16 unsaturated FP-selective prostaglandins analogs |
US8906962B2 (en) | 2000-03-31 | 2014-12-09 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US9346837B2 (en) | 2000-03-31 | 2016-05-24 | Duke University | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US9579270B2 (en) | 2000-03-31 | 2017-02-28 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
Also Published As
Publication number | Publication date |
---|---|
AU1827299A (en) | 1999-07-05 |
EP1059926A2 (fr) | 2000-12-20 |
WO1999030718A2 (fr) | 1999-06-24 |
CN1282249A (zh) | 2001-01-31 |
CA2314369A1 (fr) | 1999-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3513764B2 (ja) | 陰茎勃起機能不全を治療するための組成物および方法 | |
Waldhauser et al. | Efficiency and side effects of prostaglandin El in the treatment of erectile dysfunction | |
EP0962225A3 (fr) | Utilisation de la phentolamine pour la fabrication d'un médicament pour le traitement du dysfonctionnement érectile | |
WO1999030718A3 (fr) | COMBINAISON DE PROSTAGLANDINES E2/F2α, DESTINEE AU TRAITEMENT DE L'IMPUISSANCE ET A L'ACCROISSEMENT DE L'EXCITATION SEXUELLE | |
ZA912984B (en) | Treatment of erectile dysfunction | |
WO2003000343A3 (fr) | Administration d'inhibiteurs de phosphodiesterase destinee au traitement de l'ejaculation precoce | |
ES2152412T3 (es) | Preparacion farmaceuticamente estable de oxaliplatino. | |
US20050276865A1 (en) | Peroxide compounds for the prevention and treatment of sexual dysfunction in humans | |
BR0308137A (pt) | Formulações de droga de liberação constante contendo um peptìdeo veìculo | |
EA200400007A1 (ru) | ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ | |
NZ503890A (en) | Oral contraceptives comprising non-uterotrophic anti-estrogens and progestin | |
MY106528A (en) | Method of treating impotence. | |
AU6848098A (en) | Use of misoprostol or/and misoprostol acid for preparing drug in order to cu re erectile dysfunction | |
HUP9902094A2 (hu) | PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra | |
IL147876A0 (en) | Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence-dependent patients | |
Chew et al. | Use of transurethral alprostadil (MUSE)(prostaglandin E1) for glans tumescence in a patient with penile prosthesis | |
IT1247678B (it) | Metodo per la cura dell'impotenza erettiva maschile | |
BR0311423A (pt) | Formulação farmacêutica, uso de um progestogênio de longa ação e de um androgênio de longa ação dissolvidos em um meio oleoso farmaceuticamente aceitável, kit contraceptivo masculino para injeção, e, método de contracepção masculina | |
AU1564500A (en) | Method for obtaining and using a combination of a purine and a nitrogen monoxidedonor for preventing or treating sexual dysfunction | |
MD1568G2 (ro) | Metodă de tratament al bolii arşilor în perioada şocului combustional | |
Beauchesne | Male erectile dysfunction | |
MD1469G2 (ro) | Metodă de tratament al şocului combustional | |
WO2002072016A3 (fr) | Procede de prevention d'adherences par ifn-¿y? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98812205.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09422031 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/A/2000/005675 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2314369 Country of ref document: CA Ref document number: 2314369 Country of ref document: CA Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998963194 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1998963194 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998963194 Country of ref document: EP |